Skip to content

Targovax ASA: Announcement of Third Quarter 2018 Financial Results

26 October 2018 at 10:14:00 CET

OSLO, Norway, Oct. 26, 2018 /PRNewswire/ —

Targovax ASA (OSE: TRVX, Targovax), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, will announce its third quarter 2018 results on Thursday, 1 November 2018 at 07:00 CET.

The results report, and the presentation will be available at in the investors section from 07:00 CET.

Øystein Soug, Chief Executive Officer of Targovax, will host an online presentation for investors, analysts and the press at 08:45 CET. The presentation can be followed here, or at:

For an elaborate presentation of the Targovax strategy, please visit for a replay of the 15 October 2018 Capital Markets Day.

For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47-922-61-624

Media and IR enquires:
Andreas Tinglum – Corporate Communications (Norway)
Phone: +47-9300-1773

Simon Conway/Stephanie Cuthbert – FTI Consulting (International)
Phone: +44-20-3727-1000

This information was brought to you by Cision–announcement-of-third-quarter-2018-financial-results,c2656119

Cision View original content:

Source: Targovax